Back to search

Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients (pts) with Low-Risk Myelodysplastic Syndrome (MDS): Update Including Extended Treatment.

Hagop M. Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela S. Becker, Adam Boruchov
DOI: 10.1182/blood.v110.11.250.250
Blood

Data up to Jan 2025

Published2007
Citations44
References0
Fields
MedicineBiologyInternal medicineGastroenterologySurgery

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients (pts) with Low-Risk… (2007) – Blood | Metascience Observatory Explorer